Suppr超能文献

[抗流感神经氨酸酶抑制剂的研究进展]

[Research progress of neuraminidase inhibitors for anti-influenza].

作者信息

Liu Ai-Lin, Wang Hai-Di, Yang Fan, Du Guan-Hua

机构信息

Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

出版信息

Yao Xue Xue Bao. 2009 Sep;44(9):935-42.

Abstract

Influenza is a global contagious disease, which causes hundreds of thousands of people deaths. And new subtype of influenza may cause pandemic influenza, and lead to more serious consequence. Drugs for anti-influenza have played very important roles in influenza treatment and prevention, especially neuraminidase inhibitors are effective on both influenza A and B which have more safety and tolerance, therefore they have been widely used for influenza treatment. However, several viral drug-resistant cases have been reported. In this paper, the clinic therapy, prevention and drug resistance of neuraminidase inhibitors, including zanamivir, oseltamivir and peramivir, and progress in the research and development in our country are presented in order to promote research and development of new drugs for influenza treatment and prevention.

摘要

流感是一种全球性传染病,可导致数十万人死亡。新型流感亚型可能引发大流行性流感,并导致更严重的后果。抗流感药物在流感治疗和预防中发挥了非常重要的作用,尤其是神经氨酸酶抑制剂对甲型和乙型流感均有效,安全性和耐受性更高,因此已被广泛用于流感治疗。然而,已有几例病毒耐药病例的报道。本文介绍了扎那米韦、奥司他韦和帕拉米韦等神经氨酸酶抑制剂的临床治疗、预防及耐药情况,以及我国在其研发方面的进展,以促进流感治疗和预防新药的研发。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验